Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil
- 1 April 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 215 (1) , 1-7
- https://doi.org/10.1016/0014-2999(92)90600-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dual Mechanism of the Relaxing Effect of Nicorandil by Stimulation of Cyclic GMP Formation and by HyperpolarizationJournal of Cardiovascular Pharmacology, 1991
- Evaluation of combined effects in dose-response wstudies by statistical comparison with additive and independent interactionsJournal of Pharmacological Methods, 1990
- Nicorandil increases coronary blood flow predominantly by K-channel opening mechanismCardiovascular Drugs and Therapy, 1990
- Moving together: K+ channel openersand ATP-sensitive K+ channelsTrends in Pharmacological Sciences, 1989
- Hyperpolarizing Vasodilators Activate ATP-sensitive K + Channels in Arterial Smooth MuscleScience, 1989
- Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary arteryEuropean Journal of Pharmacology, 1989
- Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the ratBritish Journal of Pharmacology, 1989
- Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal veinBritish Journal of Pharmacology, 1986
- The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vesselsBritish Journal of Pharmacology, 1986
- Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG-75)Journal of Cardiovascular Pharmacology, 1983